| Product Code: ETC6179950 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia End Stage Renal Disease Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Australia End Stage Renal Disease Market - Industry Life Cycle |
3.4 Australia End Stage Renal Disease Market - Porter's Five Forces |
3.5 Australia End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Australia End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Australia End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Australia End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease in Australia |
4.2.2 Growing aging population leading to higher incidence of end-stage renal disease |
4.2.3 Technological advancements in renal care and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas |
4.3.2 High treatment costs associated with end-stage renal disease management |
4.3.3 Regulatory challenges and reimbursement issues in the healthcare sector |
5 Australia End Stage Renal Disease Market Trends |
6 Australia End Stage Renal Disease Market, By Types |
6.1 Australia End Stage Renal Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia End Stage Renal Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia End Stage Renal Disease Market Revenues & Volume, By Calcium Succinate, 2021- 2031F |
6.1.4 Australia End Stage Renal Disease Market Revenues & Volume, By Mk-3866, 2021- 2031F |
6.1.5 Australia End Stage Renal Disease Market Revenues & Volume, By Pacritinib, 2021- 2031F |
6.1.6 Australia End Stage Renal Disease Market Revenues & Volume, By Sanguinate, 2021- 2031F |
6.1.7 Australia End Stage Renal Disease Market Revenues & Volume, By Tesidolumab, 2021- 2031F |
6.1.8 Australia End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia End Stage Renal Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia End Stage Renal Disease Market Revenues & Volume, By Calcimimetics, 2021- 2031F |
6.2.3 Australia End Stage Renal Disease Market Revenues & Volume, By Vitamin D, 2021- 2031F |
6.2.4 Australia End Stage Renal Disease Market Revenues & Volume, By Sterols, 2021- 2031F |
6.2.5 Australia End Stage Renal Disease Market Revenues & Volume, By Potassium Binders, 2021- 2031F |
6.2.6 Australia End Stage Renal Disease Market Revenues & Volume, By Calcium-Based, 2021- 2031F |
6.2.7 Australia End Stage Renal Disease Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.3 Australia End Stage Renal Disease Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Australia End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021- 2031F |
6.3.3 Australia End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021- 2031F |
6.3.4 Australia End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021- 2031F |
6.4 Australia End Stage Renal Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Australia End Stage Renal Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia End Stage Renal Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Australia End Stage Renal Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Australia End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia End Stage Renal Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia End Stage Renal Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia End Stage Renal Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Australia End Stage Renal Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia End Stage Renal Disease Market Import-Export Trade Statistics |
7.1 Australia End Stage Renal Disease Market Export to Major Countries |
7.2 Australia End Stage Renal Disease Market Imports from Major Countries |
8 Australia End Stage Renal Disease Market Key Performance Indicators |
8.1 Average waiting time for renal transplant surgeries |
8.2 Percentage of patients receiving peritoneal dialysis as a treatment option |
8.3 Rate of adoption of home dialysis modalities |
8.4 Patient satisfaction scores with renal care facilities |
8.5 Number of research studies and clinical trials focused on end-stage renal disease treatments |
9 Australia End Stage Renal Disease Market - Opportunity Assessment |
9.1 Australia End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Australia End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Australia End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Australia End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia End Stage Renal Disease Market - Competitive Landscape |
10.1 Australia End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
10.2 Australia End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here